DE3237284C2 - - Google Patents

Info

Publication number
DE3237284C2
DE3237284C2 DE3237284A DE3237284A DE3237284C2 DE 3237284 C2 DE3237284 C2 DE 3237284C2 DE 3237284 A DE3237284 A DE 3237284A DE 3237284 A DE3237284 A DE 3237284A DE 3237284 C2 DE3237284 C2 DE 3237284C2
Authority
DE
Germany
Prior art keywords
nitroglycerin
solution
solutions
water
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3237284A
Other languages
German (de)
English (en)
Other versions
DE3237284A1 (de
Inventor
Kurt 2211 Rosdorf De Burghart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
G Pohl-Boskamp & Co Chemisch-Pharmazeutische Fabrik 2214 Hohenlockstedt De GmbH
Original Assignee
G Pohl-Boskamp & Co Chemisch-Pharmazeutische Fabrik 2214 Hohenlockstedt De GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6175236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3237284(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by G Pohl-Boskamp & Co Chemisch-Pharmazeutische Fabrik 2214 Hohenlockstedt De GmbH filed Critical G Pohl-Boskamp & Co Chemisch-Pharmazeutische Fabrik 2214 Hohenlockstedt De GmbH
Priority to DE19823237284 priority Critical patent/DE3237284A1/de
Priority to AU19792/83A priority patent/AU1979283A/en
Priority to EP83109887A priority patent/EP0108248B2/de
Priority to AT83109887T priority patent/ATE39416T1/de
Publication of DE3237284A1 publication Critical patent/DE3237284A1/de
Application granted granted Critical
Publication of DE3237284C2 publication Critical patent/DE3237284C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE19823237284 1982-10-08 1982-10-08 Loesungsvermittlerfreie, waessrige nitroglycerinloesung Granted DE3237284A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19823237284 DE3237284A1 (de) 1982-10-08 1982-10-08 Loesungsvermittlerfreie, waessrige nitroglycerinloesung
AU19792/83A AU1979283A (en) 1982-10-08 1983-09-30 Nitroglycerine solution
EP83109887A EP0108248B2 (de) 1982-10-08 1983-10-04 Lösungsvermittlerfreie, wässrige Nitroglycerinlösung
AT83109887T ATE39416T1 (de) 1982-10-08 1983-10-04 Loesungsvermittlerfreie, waessrige nitroglycerinloesung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823237284 DE3237284A1 (de) 1982-10-08 1982-10-08 Loesungsvermittlerfreie, waessrige nitroglycerinloesung

Publications (2)

Publication Number Publication Date
DE3237284A1 DE3237284A1 (de) 1984-04-12
DE3237284C2 true DE3237284C2 (ja) 1990-05-31

Family

ID=6175236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823237284 Granted DE3237284A1 (de) 1982-10-08 1982-10-08 Loesungsvermittlerfreie, waessrige nitroglycerinloesung

Country Status (4)

Country Link
EP (1) EP0108248B2 (ja)
AT (1) ATE39416T1 (ja)
AU (1) AU1979283A (ja)
DE (1) DE3237284A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007705C1 (ja) * 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
DE3109783C2 (de) * 1981-03-13 1987-04-02 Schwarz GmbH, 4019 Monheim Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml

Also Published As

Publication number Publication date
EP0108248B1 (de) 1988-12-28
EP0108248A3 (en) 1984-09-05
AU1979283A (en) 1984-04-12
ATE39416T1 (de) 1989-01-15
DE3237284A1 (de) 1984-04-12
EP0108248B2 (de) 1999-09-15
EP0108248A2 (de) 1984-05-16

Similar Documents

Publication Publication Date Title
DE69223624T2 (de) Taxan-derivate enthaltende arzneimittel
DE69328192T4 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
DE3042332C2 (ja)
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
EP0093999A2 (de) Arzneimittelzubereitungen von Oxicam-Derivaten und Verfahren zu deren Herstellung
DE68903814T2 (de) Etoposid-loesungen.
DE10133394A1 (de) Flüssige Formulierung enthaltend Cetuximab
DE3109783C2 (de) Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml
DE2506622C2 (de) Antibiotisch wirksames Arzneimittel
DE2920020C2 (ja)
DE3237284C2 (ja)
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE69016087T2 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
DE19912436A1 (de) Ibuprofen-Lösung
EP0700294B1 (de) Injektionslösung für die intramuskuläre und subkutane verabreichung an tiere
EP3099330B1 (de) Stabile alkoholische lösung von alprostadil
DE2546474A1 (de) Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
DE3509741A1 (de) Orale dosierungsform von etoposid
DE4309415C2 (de) Pharmazeutisches Präparat
DE2731013C2 (de) Verfahren zur Herstellung einer wäßrigen Infusionslösung
EP0030681B1 (de) Spritzfertige injizierbare wässrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid und Verfahren zu ihrer Herstellung
DE2445400C3 (de) Injizierbare einphasige Zubereitung und Verfahren zu ihrer Herstellung
DE2556001B2 (de) Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition